Cibc Private Wealth Group, LLC Veracyte, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $56.1 Billion
- Q3 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 886 shares of VCYT stock, worth $34,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
886
Previous 986
10.14%
Holding current value
$34,864
Previous $29,000
3.45%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
327Shares Held
78.8MCall Options Held
94.6KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA8.5MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$307 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI7.37MShares$290 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.47MShares$176 Million1.08% of portfolio
-
State Street Corp Boston, MA4.2MShares$165 Million0.01% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.82B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...